EntreMed's ENMD-2076 Demonstrates Clinical Activity in Recurrent, Platinum ... - PR Newswire (press release)

bojony.wordpress.com

EntreMed's ENMD-2076 Demonstrates Clinical Activity in Recurrent, Platinum ... PR Newswire (press release) ROCKVILLE, Md., June 3, 2011 /PRNewswire/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer today announced the presentation of clinical data for its Phase 2 study with ... and more »